Cibus Global LLC (NASDAQ:CBUS) — Market Cap & Net Worth
Market Cap & Net Worth: Cibus Global LLC (CBUS)
Cibus Global LLC (NASDAQ:CBUS) has a market capitalization of $121.52 Million ($121.52 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #18549 globally and #4316 in its home market, demonstrating a 2.52% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cibus Global LLC's stock price $1.63 by its total outstanding shares 76428964 (76.43 Million). Also see Cibus Global LLC asset portfolio for a full breakdown of the balance sheet.
Cibus Global LLC Market Cap History: 2017 to 2026
Cibus Global LLC's market capitalization history from 2017 to 2026. Data shows change from $84.19 Billion to $124.58 Million (-47.14% CAGR). Also see Cibus Global LLC (CBUS) cash conversion ratio for how efficiently the company converts equity into cash flow.
Index Memberships
Cibus Global LLC is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$41.95 Trillion | 0.00% | #1801 of 3165 |
Weight: Cibus Global LLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Cibus Global LLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cibus Global LLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check CBUS live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
36.54x
Cibus Global LLC's market cap is 36.54 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $84.19 Billion | $508.00K | -$25.98 Million | 165721.46x | N/A |
| 2018 | $39.59 Billion | $236.00K | -$27.90 Million | 167755.10x | N/A |
| 2019 | $26.79 Billion | $7.30 Million | -$39.61 Million | 3671.65x | N/A |
| 2020 | $16.13 Billion | $23.85 Million | -$44.84 Million | 676.14x | N/A |
| 2021 | $8.14 Billion | $25.99 Million | -$29.20 Million | 313.22x | N/A |
| 2022 | $565.57 Million | $157.00K | -$16.89 Million | 3602.38x | N/A |
| 2023 | $1.50 Billion | $1.82 Million | -$267.63 Million | 826.12x | N/A |
| 2024 | $212.47 Million | $4.26 Million | -$251.39 Million | 49.85x | N/A |
| 2025 | $132.99 Million | $3.64 Million | -$127.08 Million | 36.54x | N/A |
Competitor Companies of CBUS by Market Capitalization
Companies near Cibus Global LLC in the global market cap rankings as of September 18, 2026. Review Cibus Global LLC (CBUS) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Cibus Global LLC by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #185 globally with a market cap of $130.87 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #337 globally with a market cap of $79.84 Billion USD.
- CSL Ltd (AU:CSL): Ranked #455 globally with a market cap of $60.95 Billion USD ( AU$86.14 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #504 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #185 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.87 Billion | $516.34 |
| #337 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $79.84 Billion | $789.45 |
| #455 | CSL Ltd | AU:CSL | $60.95 Billion | AU$177.56 |
| #504 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $158.07 |
Cibus Global LLC Historical Marketcap From 2017 to 2026
Between 2017 and today, Cibus Global LLC's market cap moved from $84.19 Billion to $ 124.58 Million, with a yearly change of -47.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $124.58 Million | -6.32% |
| 2025 | $132.99 Million | -37.41% |
| 2024 | $212.47 Million | -85.85% |
| 2023 | $1.50 Billion | +165.41% |
| 2022 | $565.57 Million | -93.05% |
| 2021 | $8.14 Billion | -49.53% |
| 2020 | $16.13 Billion | -39.80% |
| 2019 | $26.79 Billion | -32.34% |
| 2018 | $39.59 Billion | -52.97% |
| 2017 | $84.19 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Cibus Global LLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $121.52 Million USD |
| MoneyControl | $121.52 Million USD |
| MarketWatch | $121.52 Million USD |
| marketcap.company | $121.52 Million USD |
| Reuters | $121.52 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cibus Global LLC
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-th… Read more